Our results showed that these mesostrands are valuable as immunoadjuvants for cancer immunotherapy since the mesostrands evoke strong Th1 immune response and anti-cancer immunity, increase CD4+ and CD8+ T cell populations in splenocytes of mice, and inhibit EG7-OVA tumor growth. This evidence concerns the gene CD8A and neoplasm.